Total Payments
$1,903
2024 Payments
$370.51
Companies
21
Transactions
83
Medicare Patients
30,775
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$1,903 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,903 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $317.72 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $271.41 | 12 | $0 (2024) |
| Edwards Lifesciences Corporation | $196.00 | 5 | $0 (2023) |
| iRhythm Technologies, Inc. | $163.84 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $155.18 | 9 | $0 (2024) |
| Akcea Therapeutics, Inc. | $120.83 | 1 | $0 (2019) |
| Amgen Inc. | $106.70 | 6 | $0 (2024) |
| Baxter Healthcare | $94.38 | 4 | $0 (2024) |
| PFIZER INC. | $92.28 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $78.91 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $370.51 | 19 | Novartis Pharmaceuticals Corporation ($70.42) |
| 2023 | $437.57 | 21 | Baxter Healthcare ($53.25) |
| 2022 | $357.67 | 14 | iRhythm Technologies, Inc. ($109.02) |
| 2021 | $202.50 | 11 | Janssen Pharmaceuticals, Inc ($69.11) |
| 2020 | $66.64 | 4 | Janssen Pharmaceuticals, Inc ($34.66) |
| 2019 | $194.24 | 5 | Akcea Therapeutics, Inc. ($120.83) |
| 2018 | $75.51 | 4 | Novartis Pharmaceuticals Corporation ($38.53) |
| 2017 | $198.47 | 5 | Edwards Lifesciences Corporation ($143.05) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 07/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardiology | ||||||
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Cardiovascular | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 03/06/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 02/22/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: CARDIOLOGY | ||||||
| 02/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.64 | General |
| 12/28/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Cardiology | ||||||
| 12/07/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/23/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/26/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 8,840 | 14,006 | $1.8M | $644,802 |
| 2022 | 38 | 7,347 | 12,750 | $1.5M | $542,168 |
| 2021 | 34 | 7,684 | 13,577 | $1.5M | $619,952 |
| 2020 | 37 | 6,904 | 12,614 | $1.4M | $537,663 |
Total Patients
30,775
Total Services
52,947
Medicare Billing
$2.3M
Procedure Codes
164
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 848 | 1,360 | $215,123 | $126,759 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,032 | 1,412 | $145,850 | $88,591 | 60.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 411 | 434 | $229,152 | $65,933 | 28.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 285 | 286 | $156,728 | $50,857 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 238 | 695 | $68,805 | $42,545 | 61.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 364 | 364 | $62,608 | $28,491 | 45.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,750 | 2,573 | $120,931 | $27,065 | 22.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 66 | 67 | $50,316 | $22,570 | 44.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 100 | 404 | $47,268 | $17,768 | 37.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 162 | 171 | $34,029 | $17,536 | 51.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 88 | 1,938 | $58,140 | $16,063 | 27.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 283 | 297 | $43,362 | $15,837 | 36.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 106 | 173 | $59,166 | $15,749 | 26.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 364 | 365 | $55,845 | $14,687 | 26.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 83 | 83 | $29,963 | $11,797 | 39.4% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Office | 2023 | 41 | 41 | $21,648 | $10,349 | 47.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,034 | 1,632 | $185,468 | $10,027 | 5.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 74 | $21,460 | $9,659 | 45.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 144 | 145 | $40,890 | $7,579 | 18.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 364 | 365 | $74,825 | $6,857 | 9.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 121 | 127 | $23,622 | $6,485 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 64 | $9,024 | $5,973 | 66.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 68 | 136 | $8,160 | $5,240 | 64.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $9,272 | $4,616 | 49.8% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 122 | 124 | $14,136 | $3,080 | 21.8% |
About Dr. Mark Johns, MD
Dr. Mark Johns, MD is a Cardiovascular Disease healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558350579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Johns, MD has received a total of $1,903 in payments from pharmaceutical and medical device companies, with $370.51 received in 2024. These payments were reported across 83 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,903).
As a Medicare-enrolled provider, Johns has provided services to 30,775 Medicare beneficiaries, totaling 52,947 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Midlothian, VA
- Active Since 10/21/2005
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1558350579
Products in Payments
- XARELTO (Drug) $317.72
- ENTRESTO (Drug) $177.70
- ClearSight System (Device) $143.05
- ELIQUIS (Drug) $134.59
- ZIO XT Patch (Device) $126.85
- TEGSEDI (Drug) $120.83
- Repatha (Biological) $106.70
- LEQVIO (Drug) $93.71
- Hillrom - Carnation Ambulatory Monitor (Device) $73.15
- TELEPATCH CARDIAC MONITOR (Device) $54.31
- OPTIMIZER (Device) $42.11
- NEXLETOL (Drug) $38.08
- ZIO Patch (Device) $36.99
- FUROSCIX (Drug) $30.83
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $24.26
- Hillrom - Cardiac Ambulatory Monitor (Device) $21.23
- Veltassa (Drug) $21.09
- Ozempic (Drug) $19.94
- VYNDAQEL (Drug) $19.52
- Kerendia (Drug) $19.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Midlothian
Ryan Melchior, Do, DO
Cardiovascular Disease — Payments: $47,330
Cardiovascular Disease $47,330
Omar Shams, Md, MD
Cardiovascular Disease — Payments: $35,175
Cardiovascular Disease $35,175
Dr. Calvin Newton, M.d, M.D
Cardiovascular Disease — Payments: $28,496
Cardiovascular Disease $28,496
Dr. Frederick Schnatz, D.o, D.O
Cardiovascular Disease — Payments: $10,506
Cardiovascular Disease $10,506
Dr. Ramesh Kundur, M.d, M.D
Cardiovascular Disease — Payments: $4,961
Cardiovascular Disease $4,961
Dr. Mark Warner, M.d, M.D
Cardiovascular Disease — Payments: $4,413
Cardiovascular Disease $4,413